Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$268.26 - $339.48 $909,133 - $1.15 Million
3,389 New
3,389 $925,000
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $444,460 - $602,316
1,650 New
1,650 $532,000
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $140,560 - $190,182
-391 Reduced 31.25%
860 $326,000
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $523,781 - $629,253
1,251 New
1,251 $599,000
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $296,652 - $404,983
719 New
719 $300,000
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $540,637 - $678,782
-822 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$576.64 - $649.04 $473,998 - $533,510
822 New
822 $530,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.